数字健康干预在衰弱人群中的应用:范围综述
本范围综述纳入105项研究,概述数字健康干预(DHI)在临床或社区衰弱人群中的使用情况。最常见的DHI目的为监测(43%),交付方式为传感器技术(56%),内容为用户反馈(32%),评估可行性(54%)。仅45%的研究使用经验证量表评估衰弱,14项随机对照试验中仅4项偏倚风险低或中等。
要点
- 衰弱人群中DHI研究异质性大,衰弱评估、研究设计和评价方法不统一。
- 仅45%研究使用经验证量表评估衰弱,多数研究设计为描述性探索性。
- 随机对照试验少且偏倚风险高,亟需标准化评估和高质量试验。
核心结论
- 衰弱评估、研究设计和DHI评价存在很大异质性。
- 亟需更标准化的衰弱评估方法、结构良好的随机对照试验以及恰当的评价与报告。
研究设计与样本
- 范围综述,遵循PRISMA指南,基于人群、概念和背景框架。
- 检索PubMed、Scopus和Web of Science三个数据库,无发表时间限制。
- 纳入英文原创研究,研究对象为临床或社区环境中被描述为衰弱的人群,干预为DHI。
- 共纳入105项符合标准的研究。
主要发现
- 最常见的DHI目的为监测(45项,43%)。
- 最常见的交付方式为基于传感器的技术(59项,56%)。
- 最常见的内容为用户反馈(34项,32%)。
- 57项(54%)研究评估可行性,31项(30%)报告有效性,57项(55%)报告可用性/可行性。
- 最常见的研究设计为描述性探索性新方法或技术(24项,23%)。
关键数值与推荐
- 14项(13%)为随机对照试验,其中仅4项(29%)显示低或中等偏倚风险。
- 仅47项(45%)研究报告使用经验证量表评估衰弱。
临床怎么用
- 临床使用DHI于衰弱人群时,应注意现有研究异质性大且高质量证据有限。
- 应优先选择使用经验证量表评估衰弱并报告可用性/可行性的DHI。
局限性
- 纳入研究在衰弱评估、研究设计和DHI评价方面异质性大。
- 随机对照试验数量少且多数偏倚风险高。
- 仅45%研究使用经验证量表评估衰弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Digital health interventions (DHIs) are interesting resources to improve various health conditions. However, their use in the older and frail population is still sparse. We aimed to give an overview of DHI used in the frail older population. DESIGN: Scoping review with PRISMA guidelines based on Population, Concept, and Context. SETTING AND PARTICIPANTS: We included original studies in English with DHI (concept) on people described as frail (population) in the clinical or community setting (context) and no limitation on date of publication. We searched 3 online databases (PubMed, Scopus, and Web of Science). MEASURES: We described DHI in terms of purpose, delivering, content and assessment. We also described frailty assessment and study design. RESULTS: We included 105 studies that fulfilled our eligibility criteria. The most frequently reported DHIs were with the purpose of monitoring (45; 43%), with a delivery method of sensor-based technologies (59; 56%), with a content of feedback to users (34; 32%), and for assessment of feasibility (57; 54%). Efficacy was reported in 31 (30%) studies and usability/feasibility in 57 (55%) studies. The most common study design was descriptive exploratory for new methodology or technology (24; 23%). There were 14 (13%) randomized controlled trials, with only 4 of 14 studies (29%) showing a low or moderate risk of bias. Frailty assessment using validated scales was reported in only 47 (45%) studies. CONCLUSIONS AND IMPLICATIONS: There was much heterogeneity among frailty assessments, study designs, and evaluations of DHIs. There is now a strong need for more standardized approaches to assess frailty, well-structured randomized controlled trials, and proper evaluation and report. This work will contribute to the development of better DHIs in this vulnerable population.
引用
- Linn N, Goetzinger C, Regnaux JP, et al. Digital Health Interventions among People Living with Frailty: A Scoping Review. J Am Med Dir Assoc. 2021. PMID: 34000266. doi:10.1016/j.jamda.2021.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。